No glycemic benefit from guar administration in NIDDM.
A randomized crossover study of 5-g guar minitablets against placebo, given three times per day with main meals for 8 wk, was done in 29 non-insulin-dependent diabetes mellitus (NIDDM) patients who had near-normal fasting plasma glucose concentrations on treatment with diet alone, additional sulfony...
Autores principales: | Holman, R, Steemson, J, Darling, P, Turner, R |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
1987
|
Ejemplares similares
-
LACK OF BENEFIT FROM GUAR ADMINISTRATION IN WELL CONTROLLED NON-INSULIN-DEPENDENT DIABETIC-PATIENTS
por: Holman, R, et al.
Publicado: (1984) -
Insulin use in NIDDM. Rationale based on pathophysiology of disease.
por: Turner, R, et al.
Publicado: (1990) -
Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
por: Cull, C, et al.
Publicado: (1997) -
Effects of ethnicity on metabolic control during the first six years of NIDDM
por: Davis, T, et al.
Publicado: (1997) -
Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
por: Turner, R, et al.
Publicado: (1997)